Unknown

Dataset Information

0

Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.


ABSTRACT: Vaccines offer an option to treat heroin and prescription opioid abuse and prevent fatal overdoses. Opioid vaccines elicit antibodies that block opioid distribution to the brain and reduce opioid-induced behavioral effects and toxicity. The major limitation to the translation of addiction vaccines is that efficacy is observed only in subjects achieving optimal drug-specific serum antibody levels. This study tested whether efficacy of a vaccine against oxycodone is increased by immunomodulators targeting key cytokine signaling pathways involved in B and T cell lymphocyte activation. Blockage of IL-4 signaling increased vaccine efficacy in blocking oxycodone distribution to the brain and protection against opioid-induced behavior and toxicity in mice. This strategy generalized to a peptide-protein conjugate immunogen, and a tetanus-diphtheria-pertussis vaccine. These data demonstrate that cytokine-based immunomodulators increase efficacy of vaccines against small molecules, peptides and proteins, and identify IL-4 as a pharmacological target for improving efficacy of next-generation vaccines.

SUBMITTER: Laudenbach M 

PROVIDER: S-EPMC5882912 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.

Laudenbach Megan M   Baruffaldi Federico F   Robinson Christine C   Carter Philipp P   Seelig Davis D   Baehr Carly C   Pravetoni Marco M  

Scientific reports 20180403 1


Vaccines offer an option to treat heroin and prescription opioid abuse and prevent fatal overdoses. Opioid vaccines elicit antibodies that block opioid distribution to the brain and reduce opioid-induced behavioral effects and toxicity. The major limitation to the translation of addiction vaccines is that efficacy is observed only in subjects achieving optimal drug-specific serum antibody levels. This study tested whether efficacy of a vaccine against oxycodone is increased by immunomodulators t  ...[more]

Similar Datasets

| S-EPMC11792077 | biostudies-literature
2020-08-31 | GSE157144 | GEO
| S-EPMC6719534 | biostudies-literature
| S-EPMC5663400 | biostudies-literature
| S-EPMC7578047 | biostudies-literature
| S-EPMC4162783 | biostudies-literature
| S-EPMC8957260 | biostudies-literature
| S-EPMC5975355 | biostudies-literature
| S-EPMC6800078 | biostudies-literature
| S-EPMC11498215 | biostudies-literature